4/2
08:43 am
nxl
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial [Yahoo! Finance]
Neutral
Report
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial [Yahoo! Finance]
4/2
08:30 am
nxl
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial
Medium
Report
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial
3/26
08:42 am
nxl
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3 [Yahoo! Finance]
Low
Report
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3 [Yahoo! Finance]
3/26
08:30 am
nxl
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3
Low
Report
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3
3/24
08:09 am
nxl
Nexalin Technology, Inc. (NASDAQ: NXL) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock.
Medium
Report
Nexalin Technology, Inc. (NASDAQ: NXL) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock.
3/3
08:57 am
nxl
Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders [Yahoo! Finance]
Medium
Report
Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders [Yahoo! Finance]
3/3
08:30 am
nxl
Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders
High
Report
Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders
2/28
10:53 am
nxl
Nexalin Technology Announces Initiation of Patient Recruitment for UCSD's TBI & PTSD Clinical Study Following IRB Approval [Yahoo! Finance]
Medium
Report
Nexalin Technology Announces Initiation of Patient Recruitment for UCSD's TBI & PTSD Clinical Study Following IRB Approval [Yahoo! Finance]
2/28
08:30 am
nxl
Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval
Medium
Report
Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval
2/26
08:30 am
nxl
Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board
Low
Report
Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board
2/18
08:40 am
nxl
Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment [Yahoo! Finance]
Low
Report
Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment [Yahoo! Finance]
2/18
08:30 am
nxl
Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment
Low
Report
Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment
2/10
10:01 am
nxl
Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition [Yahoo! Finance]
Low
Report
Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition [Yahoo! Finance]
2/10
09:00 am
nxl
Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition
Medium
Report
Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition
2/3
09:43 am
nxl
Nexalin's Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study [Yahoo! Finance]
Medium
Report
Nexalin's Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study [Yahoo! Finance]
2/3
08:30 am
nxl
Nexalin’s Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study
High
Report
Nexalin’s Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study
1/23
11:00 am
nxl
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23
Low
Report
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23
1/14
09:33 am
nxl
Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025 [Yahoo! Finance]
Low
Report
Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025 [Yahoo! Finance]
1/14
08:30 am
nxl
Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025
Medium
Report
Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025